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SERS detection of the biomarker 
hydrogen cyanide from 
Pseudomonas aeruginosa cultures 
isolated from cystic fibrosis 
patients
Rikke Kragh Lauridsen1, Lea M. Sommer2, Helle Krogh Johansen2,3, Tomas Rindzevicius1, 
Søren Molin2, Lars Jelsbak4, Søren Balling Engelsen5 & Anja Boisen1
Pseudomonas aeruginosa is the primary cause of chronic airway infections in cystic fibrosis (CF) patients. 
Persistent infections are seen from the first P. aeruginosa culture in about 75% of young CF patients, 
and it is important to discover new ways to detect P. aeruginosa at an earlier stage. The P. aeruginosa 
biomarker hydrogen cyanide (HCN) contains a triple bond, which is utilized in this study because of the 
resulting characteristic C≡N peak at 2135 cm−1 in a Raman spectrum. The Raman signal was enhanced 
by surface-enhanced Raman spectroscopy (SERS) on a Au-coated SERS substrate. After long-term 
infection, a mutation in the patho-adaptive lasR gene can alter the expression of HCN, which is why it is 
sometimes not possible to detect HCN in the breath of chronically infected patients. Four P. aeruginosa 
reference strains and 12 clinical P. aeruginosa strains isolated from CF children were evaluated, and HCN 
was clearly detected from overnight cultures of all wild type-like isolates and half of the later isolates 
from the same patients. The clinical impact could be that P. aeruginosa infections could be detected 
at an earlier stage, because daily breath sampling with an immediate output could be possible with a 
point-of-care SERS device.
Individuals with cystic fibrosis (CF) have an inherited defect in the cystic fibrosis transmembrane conductance 
regulator (CFTR) gene, causing thickened, dehydrated mucus to form on mucociliary surfaces. This in turn 
increases the risk of e.g. airway infections. Pseudomonas aeruginosa lung infections are the largest threat to the 
wellbeing and survival of CF patients, and it has been shown for a cohort of young Danish CF patients that an 
estimated 75% have a persistent infection already from the first detection of P. aeruginosa1.
If the child is unable to expectorate, today’s methods consist of either a larynx swab, which is insensitive, or 
induced sputum (naso-laryngeal suction), which is extremely invasive. P. aeruginosa can be difficult to detect, 
especially in children and young adults without a chronic infection because they have few bacteria in their air-
ways. Therefore more sensitive and non-invasive methods are being investigated utilizing the fact that hydrogen 
cyanide (HCN) is a biomarker for P. aeruginosa2–4. In nature, P. aeruginosa emits the poisonous gas HCN in order 
to kill competitive microorganisms. This wildtype (WT)-like behavior is also expected to occur in the lungs, at 
least during the initial stages of infection. To sustain a persistent colonisation and infection, adaptation is neces-
sary. In many cases this involves mutations of different genes, so-called “patho-adaptive” genes. One of the genes 
that have been suggested as being “patho-adaptive” (i.e. beneficial for P. aeruginosa to mutate) is lasR5,6. The lasR 
gene is a transcriptional regulator necessary for HCN production7, so a mutation in the lasR gene can imply a 
change in the bacterial emission of HCN. According to the clinical CF program in Denmark, patients are seen 
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once a month in the outpatient clinic and deliver a sputum sample coughed up from the lungs. Depending on 
the patient’s age and ability this is either done by expectoration or, as in most young patients, induced by a tube 
inserted through the nose into the larynx to provoke a cough reflex after which a sample is obtained through the 
tube (naso-laryngeal suction). Sputum samples are then cultured to identify pathogenic microorganisms.
Several groups have investigated HCN production by P. aeruginosa in vitro3,8,9. The drawbacks of all the 
applied methods are that they need extensive sample handling before measurements can be obtained, and that it 
can only be done in solution. To the best of our knowledge, selected ion flow tube – mass spectroscopy (SIFT-MS) 
is the current state-of-the-art method in terms of sensitivity and specificity10. However, it is also an expensive 
and complex procedure. The technique was employed in the study by Enderby et al.2, where median values of 
13.5 ppb HCN were detected directly in the breath of CF children with a newly discovered P. aeruginosa lung 
colonization2, whereas in the more recent study by Gilchrist et al.10, HCN concentrations at or below 7.5 ppb were 
detected from breath samples collected in bags and measured within 24 hours10. An optimal sensor would be a 
cheap and simple point-of-care device, allowing for measurements to be carried out directly on human breath, 
without pre-handling of the samples. The so-called surface-enhanced Raman scattering (SERS) technique can 
potentially fulfill these requirements since hand-held Raman spectrometers are progressively becoming cheaper, 
better and smaller11.
Raman spectroscopy is a fingerprinting technique that measures the inelastic scattering of monochromatic 
light when interacting with matter. The frequency shift (Raman shift) of the inelastically scattered light corre-
sponds to the energies of the molecular vibrations12. HCN contains a triple bond between C and N, which will 
result in a Raman band around 2135 wavenumbers (cm−1). But since the inelastically scattered light is only a 
tiny part of light scattered from a sample (< 10−8), Raman spectroscopy in general has a weak signal-to-noise 
ratio, and there is a need for signal enhancement. Using SERS, the Raman signal of small molecules is enhanced 
by utilizing the collective oscillations of conducting electrons (surface plasmons) that take place in the vicinity 
of clustered noble-metal nanoparticles13,14. SERS has been used in a wide array of medical applications15–17. An 
example hereof is using label free Ag colloid SERS to detect single-nucleotide mismatch in short DNA sequences 
to discover even small nucleotide changes18. We have demonstrated previously that the SERS technique is suit-
able for cyanide quantification with the estimated lower limit of detection between 1.8 and 18 ppb using highly 
sensitive gold-coated silicon (Si) nanopillar SERS substrates19. These substrates consist of vertically standing Si 
nanopillars with gold (Au) caps which can lean against each other for enhanced SERS detection in liquid or gas 
phase20. In this study we utilize identical SERS substrates and investigate the capability of the method to detect 
the biomarker HCN(g) in emissions from clinical early and late P. aeruginosa isolates. In order to determine its 
applicability as a non-invasive diagnostic tool for detection of P. aeruginosa we qualitatively evaluate results which 
indicate HCN presence in gases from early P. aeruginosa isolates, and since our SERS substrate is able to detect 
ppb values of HCN, this novel method is expected to be able to discover P. aeruginosa from breath at an earlier 
stage than by using today’s clinical practice.
Materials and Methods
Preparation of the SERS substrate. The disposable SERS substrate was etched in a single-side polished 
Si wafer using 3 min Reactive Ion (plasma) Etching with alternating SF6 bombardment and O2 protection of the 
emerging nanopillars, followed by a 1 min O2 cleaning step. Before use, Au was evaporated onto the Si nano-
pillars, forming 225 nm caps used for SERS detection. See Fig. 1(a). On the day of exposure the wafer was cut 
into 6 × 6 mm chips using a diamond cutter and tweezers. The chips were cleaned by immersion into ethanol 
(Absolute grade, CHROMASOLV R, Sigma-Aldrich) for 3 min followed by H2O (Molecular Biology Reagent 
grade, Sigma-Aldrich) for 3 min and left to dry on a tissue whereby the pillars would lean to enable SERS detec-
tion. For easy handling and transportation, the SERS substrate was mounted inside a small Petri dish, using 
double sided adhesive tape (Scotch), with a Post-It on top, the tacky side facing up for holding the substrate 
Figure 1. Setup for SERS measurements on bacterial volatiles. (a) SEM images of the SERS substrate before 
and after leaning for formation of electromagnetic “hot spots” for SERS enhancement. (Courtesy of Kaiyu 
Wu. Reprinted with permission from editor of ref. 19). (b) The pump (1) induces a vacuum inside the vacuum 
chamber (2), leading to inflation of the bag (3) and exposure of the SERS substrate (4) to volatiles created by the 
bacterial culture (5) in the water bath (6).
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(Fig. 1(b,4). The wall of the Petri dish protected the delicate SERS substrate so it would not get in contact with the 
bag and be scratched (See section on SERS substrate exposure to bacterial emissions).
P. aeruginosa reference strains. PAO1 is a reference strain commonly used to benchmark various P. 
aeruginosa strains against. PA-SD2 is a PAO1 isolate with a knockout mutation in lasR, as described in ref. 20. 
DK02 is a P. aeruginosa lineage that spread among Danish CF patients for over 40 years. The earliest isolate is 
called DK02-1973, and its lasR mutated strain DK02-197921. All four reference strains were evaluated in the study.
The children strain collection. At the CF clinic at Rigshospitalet in Copenhagen a special collection of 
bacterial strains has been sampled from CF children and young adults since 2004, resulting in a unique collection 
for genomics and other evolutional studies to be made5,22. From this collection early (lasR WT) and late (lasR 
mutant) isolates from five patients have been selected, encompassing three different clone types, for comparison 
of adaptations between and within patients. The selected strains originate from CF patients who today are all 
chronically infected, and the late isolates represent various locations of lasR mutations. Selected strains include 
the first P. aeruginosa isolate and at least one later isolate from the same patient after onset of chronicity and with 
detected mutations in the lasR gene. From the children strain collection, 12 P. aeruginosa isolates were evaluated.
Ethics. The local ethics committee at the Capital Region of Denmark Region Hovedstaden approved the use of 
the samples: registration number H-4-2015-FSP. All patients have given informed consent. For patients below 18 
years of age, informed consent was obtained from their parents. The study was carried out in accordance with the 
approved guidelines and the University Hospital Rigshospitalet approved the experimental protocol.
Identification of mutations in lasR. Using a modified version of the pipeline previously described in 
Andersen et al.23, we identified mutations in the CF isolates using the sequences of isolates from young CF 
patients, previously published by Marvig et al. (2015)5. Briefly: Reads were mapped to the lasR reference sequence 
(NP_250121.1) from the reference strain Pseudomonas aeruginosa PAO1, using the Burrows-Wheeler alignment 
tool24 (BWA version 0.7.12), with the paired-end reads setting. Alignments were filtered to remove unmapped 
reads, sorted, and indexed using SAMtools25. Each isolate was assigned to a read group using Picard Tools 
(open-source software version 1.14, http://pickard.sourceforge.net) and differences between isolates and the ref-
erence lasR sequence were identified with SAMtools. Mutations were manually checked using the Integrative 
Genomics Viewer26 (IGV, version 2.3.68). The functional impact (missense/nonsense/silent) was determined 
using the translated sequence of lasR in the IGV. The full pipeline can be found in Supplementary material.
Preparation of bacterial cultures. P. aeruginosa strain PAO1, its engineered lasR mutant PA-SD2 and 
two isolates from the classic clinical lineage DK02 from 1973 and 197927, as well as P. aeruginosa strains from five 
paediatric CF patients were stored as pure cultures at − 80 °C, wherefrom they were streaked onto LB agar plates 
and incubated at 37 °C over night (ON). One colony was then inoculated in 10 mL LB growth medium (4% salt 
concentration) and incubated shaking at an angle of ~45°, 225 rpm overnight ON. One mL of the ON culture was 
added to 9 mL of fresh LB in a 100 mL Erlenmeyer flask, plugged with a two-holed rubber plug, covered with alu-
minum foil and placed in a 37 °C water bath at ~200 rpm ON, wherefrom SERS substrates were exposed (Fig. 1). 
One flask was prepared for each measurement needed.
SERS substrate exposure to bacterial emissions. In the setup we used an SK 224-PCMTX4 Universal 
air sampling pump (SKC Inc., PA, US), connected via a silicone tube to a large Vac-U-Chamber, 231–939 
(SKC Inc., PA, US), Fig. 1(b,1–2). Inside the vacuum chamber a 10 L reusable 60 μ m PTFE (Teflon) sample bag 
(Scentroid, ON, Canada), equipped with a 1/2” compression fitting was connected to the sample inlet (3). The 
bag was specially designed with one end open for mounting the SERS substrate, and closed by a clamp. The 
sample inlet of the vacuum chamber was connected via a silicone tube to the 100 mL Erlenmeyer culture flask 
(5), plugged with a rubber plug with two holes, one for the tube and one for air inlet. The pump was operating 
at ~500 mL/min for 15 min to fill the bag, followed by 5 min holding time for further substrate exposure. Before 
pumping out bacterial gases, all fittings were tested by closing the vacuum chamber and turning on the pump 
to let in air from the lab to verify that the bag would inflate and no emissions would be lost when the bacterial 
culture was connected to the system.
OD and SERS measurements. The Optical density (OD) was measured at 600 nm in a UV-1800 spectro-
photometer (SHIMADZU, Kyoto, Japan), giving the absorbance as a measure of cell density. SERS measurements 
were recorded using a FT-Raman instrument (Bruker VERTEX 70, Bruker Optik, Ettlingen, Germany), equipped 
with a 1064 nm laser and an InGaAs detector. Samples were measured in a 180 degrees backscattering geometry 
using 32 scans at a resolution of 4 cm−1. Each sample was measured at 5 different positions on the substrate and 
the 5 spectra were averaged before subsequent data analysis.
Results and Discussion
SERS on PAO1 and DK02 ON culture emissions. The clinical strains were growing much slower than 
PAO1, and ON cultures were prepared for SERS exposure and measurements. In Fig. 2(a,b) it is seen that PAO1 
and the isolate from 1973 both emitted substantial amounts of HCN, as seen in the intense C≡ N stretching peak 
at 2135 cm−1, whereas the lasR mutated PAO1 and the late (1979) isolate did not. This was as expected since the 
late DK2 and the lasR mutated PAO1 should not have a functional LasR protein.
HCN emission from PAO1 during growth. As seen in the growth curve of Fig. 3(a), PAO1 has a lag phase 
of about 2 hours before onset of exponential growth, with stationary growth, and expected HCN production, 
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beginning after 4–6 hours. According to previous studies HCN production starts at the end of exponential/begin-
ning of stationary phase8,28. This is due to the fact that HCN production is quorum sensing (QS) dependent. After 
a few hours on the substrate much of the C≡ N peak had shifted to 2189 cm−1 because of sufficient amounts and 
the fact that it had had some time to interact with the Au-coated SERS substrate, forming the stabile [Au(CN)2]− 
complex, as explained in ref. 19. Figure 3(b) shows the SERS intensity of the cumulated cyanide peaks at 2135 
and 2189 cm−1 from 2 until 20 h (ON). It is observed that HCN production begins after 4 h growth and is still 
detectable in the overnight (20 h) culture, whereas the 2 and 3 h samples only had the same background as the LB 
reference. The results in Fig. 3(b) and the shape of the HCN emission curve with time are very similar to previous 
findings8,29.
HCN emission from P. aeruginosa strains isolated from CF children. A total of 12 isolates from five 
CF children were measured with the SERS sensor in the developed setup. In Fig. 4 the intensity of the 2135 cm−1 
C≡ N stretching band shows that all early (WT-like) strains and also some of the lasR mutated strains isolated 
from paediatric CF patients emitted HCN. Thereby, the principle had been proven that the SERS substrate was 
able to detect HCN from cultures of early P. aeruginosa colonizations, which was the aim of the study. Since it was 
possible to detect HCN from emissions of all early ON cultures, it was plausible that HCN could also be detected 
from breath of a patient with an early P. aeruginosa colonization. Genome sequencing of the lasR mutated isolates5 
showed that isolates with lasR mutations located towards the 3′ terminal of the gene did not produce HCN, and 
it was an interesting finding that only lasR mutated cultures with the mutation located upstream or at the central 
part of the gene emitted detectable HCN. The continued production of HCN could be explained by mutations 
or changes in regulation of other genes that are also important for QS and HCN production circumventing a 
malfunctioning lasR.
Clinical control strains. To make sure HCN could be used as a specific marker for P. aeruginosa colonisa-
tion, we also tested other clinically relevant species. Figure 5 shows examples of two other bacteria colonising 
the lungs of CF patients, and known to be able to cause chronic infections: Stenotrophomonas maltophilia30 and 
Figure 2. SERS on overnight cultures of PAO1, the DK02 lineage and their lasR mutated strains. (a) SERS 
on emissions from overnight cultures of P. aeruginosa PAO1, wild type vs. its engineered lasR mutated strain 
PA-SD2. (b) SERS on emissions from overnight cultures of the P. aeruginosa DK02 lineage, wild type from 1973 
vs. the lasR mutated strain from 1979. Both wild types show intense CN signals at 2135 cm−1 and also a small 
peak at 2189 cm−1 due to formation of the [Au(CN)2]− complex, whereas the lasR mutated strains emit no HCN. 
Spectra of LB emissions are included as reference.
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Figure 3. PAO1 HCN emission during growth. (a) Optical density (OD600) growth curve for PAO1 in LB 
medium at 37 °C. The lag phase takes about 2 hours, followed by the log phase until about 4–6 hours’ growth 
after which the stationary state occurs. Final OD absorbance is about 1.7 at 600 nm. (b) Intensity of cumulated 
cyanide peaks from PAO1 during growth. The cumulated Raman intensity is the (2135 + 2189) cm−1 SERS 
intensity on the PAO1 exposed substrate minus the background signal of the substrate exposed to LB emissions. 
It is seen that PAO1 starts producing HCN after 4 hours’ growth, which is at the end of its exponential/
beginning of stationary growth phase. After 20 hours HCN is still detectable, although not as intense as 
after 4 hours. The shape of the CN curve resembles previous studies on P. aeruginosa HCN emission during 
growth8,28.
Figure 4. Cyanide production of clinical P. aeruginosa overnight cultures from 5 CF patients. The peak 
intensity is the SERS signal at 2135 cm−1 minus the background signal of the LB reference samples. It is seen that 
all WT-like isolates emitted clearly detectable HCN, and so did also some of the lasR mutated isolates. The latest 
isolates from patients C, D and E did not emit HCN.
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Achromobacter xylosoxidans31. Clinical isolates of these control strains were tested in the same setup as P. aerugi-
nosa, but no HCN could be detected. The findings were in accordance with Bumunang & Babalola32.
Conclusions and Outlook
We have developed a SERS-based method for detection of HCN from P. aeruginosa cultures, and a setup for expo-
sure of the SERS substrate to bacterial volatiles. The purpose was to see whether the wild type like strains were 
producing HCN in sufficient amounts for detection by the SERS substrate and to check whether the lasR mutated 
strains were still producing HCN. For the reference strain PAO1 HCN production started at the end of stationary 
phase and was still detectable in overnight cultures. In all clinical wild type-like strains isolated from the airways 
of cystic fibrosis patients there was a clear HCN SERS signal proving the principle that we are able to detect gases 
from early P. aeruginosa isolates. HCN could only be detected from half of the strains with mutation in the lasR 
transcriptional regulator gene, which may explain why HCN cannot be detected in the breath of all patients with 
a chronic P. aeruginosa airway infection.
We acknowledge the possible limitations to this SERS-based breath device, which could have a slightly lower 
sensitivity than SIFT-MS, which seems to be state-of-the-art for breath detection of HCN. General limitations 
to ppb level breath detection could be that the child has recently been coughing, whereby the low amounts of 
bacterial volatiles could be lost, or that the child is too young and unable to exhale properly. Another issue could 
be if the infection is already chronic and P. aeruginosa has stopped to emit HCN. Still, our results suggest that it is 
indeed possible to use SERS detection of HCN as an early indicator of P. aeruginosa infection. The method offers 
the possibility of a simple, non-invasive point-of-care monitoring device, which could be used in the patients’ 
home or at the general practitioner for more frequent breath measurements, hopefully leading to an earlier detec-
tion of P. aeruginosa lung infections in patients with CF.
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